Home
Technology
Areas of use
Market
News & Media
- News Feed
- Articles in Media
About us
Career
Contact

News Feed

New issues of shares

New issues of shares of 232 570 shares at 30 SEK per share

Prev
Next

Press Contact

ulf sewerin

Ulf Sewerin, CEO
Telephone: +46 13 210060
Mobile: +46 708 797988
E-mail: ulf.sewerin@addbio.se

Disclaimer: This product is in clinical evaluation pending marketing approval

© 2019 AddBIO AB | Teknikringen 10 | SE-583 30 Linköping | Sweden | +46 13 21 00 60 | www.addbio.se | info@addbio.se

Home
Technology
Areas of use
Market
News & Media
- News Feed
- Articles in Media
About us
Career
Contact

This is an archive